HFZS
839725
GLORIA
831641
Y&J CO.,LTD.
833943
COCYBER
835207
Sichuan Etrol Technologies
300370
CN Stock MarketDetailed Quotes
002524 Guangzheng Eye Hospital Group
- 4.59
- +0.04+0.88%
Not Open Dec 3 15:00 CST
2.38BMarket Cap-109285P/E (TTM)
4.60High4.49Low204.58KlotVolume4.54Open4.55Pre Close93.21MTurnover4.03%Turnover Ratio255.00P/E (Static)518.47MShares6.6752wk High8.73P/B2.33BFloat Cap2.9052wk Low5.01Limit Up508.30MShs Float18.85Historical High4.10Limit Down2.42%Amplitude2.66Historical Low--Dividend TTM4.56Avg Price100.52KlotAsk--Div YieldTTM100Lot Size101.45KlotBid
Guangzheng Eye Hospital Group Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -15.49%698.78M | -11.81%481.9M | -7.78%199.54M | 40.06%1.07B | 44.49%826.83M | 60.08%546.41M | 16.23%216.37M | -26.52%767.44M | -26.51%572.26M | -35.38%341.34M |
| Operating revenue | -15.49%698.78M | -11.81%481.9M | -7.78%199.54M | 40.06%1.07B | 44.49%826.83M | 60.08%546.41M | 16.23%216.37M | -26.52%767.44M | -26.51%572.26M | -35.38%341.34M |
| Other operating revenue | ---- | 11.29%16.28M | ---- | 39.95%33.85M | ---- | 36.77%14.63M | ---- | 37.06%24.19M | ---- | -3.82%10.7M |
| Total operating cost | -12.41%722.12M | -9.99%487.19M | 0.14%222.62M | 19.95%1.08B | 26.86%824.46M | 33.60%541.28M | 0.32%222.32M | -18.63%897.08M | -20.08%649.92M | -24.85%405.15M |
| Operating cost | -19.73%440.91M | -17.18%298.7M | -6.03%132.66M | 21.19%697.94M | 30.88%549.28M | 38.55%360.64M | 0.78%141.17M | -18.79%575.92M | -18.53%419.69M | -23.90%260.29M |
| Operating tax surcharges | -15.63%3.43M | -13.60%2.01M | -15.23%1.19M | 0.61%4.78M | 3.11%4.07M | 20.96%2.33M | -1.12%1.4M | -13.75%4.75M | -21.41%3.95M | -39.16%1.93M |
| Operating expense | 3.28%143.71M | 7.71%96.4M | 11.32%43.41M | 32.77%187.06M | 34.94%139.15M | 45.10%89.5M | 6.37%39M | -29.76%140.89M | -32.87%103.12M | -38.28%61.68M |
| Administration expense | 2.97%103.51M | 1.27%69.2M | 12.68%35.25M | 2.22%140.95M | 4.52%100.53M | 8.19%68.33M | -8.63%31.28M | -4.68%137.88M | -11.35%96.18M | -13.71%63.16M |
| Financial expense | -4.11%28.66M | 0.35%19.63M | 3.68%9.82M | 9.68%40.34M | 13.07%29.89M | 10.61%19.57M | 6.24%9.47M | -4.59%36.77M | -9.00%26.44M | -10.77%17.69M |
| -Interest expense (Financial expense) | -2.66%28.34M | -0.33%18.96M | 3.57%9.51M | 6.65%38.75M | 11.83%29.11M | 9.18%19.02M | 5.64%9.18M | -3.66%36.34M | -8.39%26.03M | -10.98%17.42M |
| -Interest Income (Financial expense) | -51.32%-938.03K | 35.67%-185.36K | 42.94%-90.82K | 22.06%-690.15K | 15.59%-619.88K | 20.02%-288.12K | 1.20%-159.18K | -21.96%-885.49K | -32.28%-734.35K | 12.05%-360.22K |
| Research and development | 21.72%1.88M | 36.68%1.25M | --292.57K | 480.29%4.97M | 184.02%1.54M | 122.75%916.66K | ---- | -78.39%855.68K | -71.88%543.22K | -56.51%411.53K |
| Credit Impairment Loss | -137.14%-1.49M | -87.41%436.18K | 1,436.38%518.95K | -137.49%-447.3K | 356.79%4.01M | 700.16%3.46M | 117.48%33.78K | -73.91%1.19M | -92.16%876.91K | -75.24%432.82K |
| Asset Impairment Loss | 25.51%-253.14K | 30.79%-243.7K | ---- | 97.88%-2.98M | -229.26%-339.84K | -233.92%-352.1K | ---- | -2,269.93%-140.1M | 136.71%262.93K | 136.71%262.93K |
| Other net revenue | -3.94%12.55M | 391.49%12.07M | 1,319.97%4.41M | 105.25%8.16M | 561.37%13.07M | 26.30%2.46M | -210.36%-361.81K | -245.74%-155.48M | -97.70%1.98M | -97.44%1.94M |
| Invest income | 1,269.95%8.3M | 301.79%6.58M | 392.31%3.57M | 103.85%788.97K | 71.08%-709.72K | -160.33%-3.26M | -124.50%-1.22M | -125.44%-20.51M | -103.42%-2.45M | -101.74%-1.25M |
| -Including: Investment income associates | 98.91%-49.62K | 98.89%-35.8K | 93.17%-71.16K | 79.10%-4.43M | -41.91%-4.55M | -81.12%-3.24M | -38.67%-1.04M | -288.59%-21.18M | -35.10%-3.21M | -27.81%-1.79M |
| Asset deal income | 229.93%4.94M | 503.07%4.93M | ---- | 63.07%1.7M | 133.59%1.5M | 175.05%817.67K | 939.97%395.52K | -85.53%1.04M | -41.32%641.5K | -72.15%297.28K |
| Other revenue | -87.87%1.04M | -79.29%370.24K | -23.86%327.03K | 214.32%9.09M | 225.16%8.61M | -18.90%1.79M | -26.24%429.51K | -85.69%2.89M | 6.06%2.65M | 19.83%2.2M |
| Operating profit | -169.86%-10.79M | -10.49%6.78M | -195.85%-18.67M | 102.47%7.03M | 120.40%15.44M | 112.25%7.58M | 82.26%-6.31M | -685.28%-285.12M | -247.39%-75.68M | -195.21%-61.87M |
| Add:Non operating Income | -74.59%250.17K | -47.83%224.33K | -95.14%27.17K | -98.34%3.53M | -99.54%984.57K | 81.87%430.02K | 642.78%558.98K | 30,994.12%212.39M | 107,553.70%212.47M | 99.83%236.45K |
| Less:Non operating expense | 128.41%4.8M | 111.29%3M | 100.93%610.98K | -7.21%2.64M | -2.63%2.1M | 9.09%1.42M | -69.64%304.08K | -36.16%2.85M | -18.96%2.16M | 207.53%1.3M |
| Total profit | -207.10%-15.34M | -39.12%4.01M | -217.94%-19.25M | 110.47%7.91M | -89.36%14.32M | 110.47%6.59M | 83.41%-6.05M | -268.20%-75.58M | 175.43%134.63M | -197.30%-62.94M |
| Less:Income tax cost | 105.47%4.95M | 538.43%3.12M | -110.59%-134.11K | -182.50%-1.83M | 56.41%2.41M | -37.57%488.74K | 353.49%1.27M | -73.84%2.22M | -54.06%1.54M | -79.81%782.87K |
| Net profit | -270.24%-20.28M | -85.36%893.49K | -161.13%-19.12M | 112.53%9.75M | -91.05%11.92M | 109.58%6.1M | 79.66%-7.32M | -313.49%-77.8M | 192.31%133.09M | -204.79%-63.72M |
| Net profit from continuing operation | -270.24%-20.28M | -85.36%893.49K | -161.13%-19.12M | 112.53%9.75M | -91.05%11.92M | 109.58%6.1M | 79.66%-7.32M | -313.49%-77.8M | 192.31%133.09M | -204.79%-63.72M |
| Less:Minority Profit | -64.57%524.17K | -140.85%-380.45K | -173.64%-389.47K | 18.10%491.16K | 70.11%1.48M | 2,298.83%931.43K | 531.12%528.92K | 185.94%415.88K | 286.61%869.76K | 91.18%-42.36K |
| Net profit of parent company owners | -299.40%-20.81M | -75.37%1.27M | -138.57%-18.73M | 111.83%9.26M | -92.11%10.44M | 108.12%5.17M | 78.24%-7.85M | -311.82%-78.22M | 187.45%132.22M | -203.90%-63.68M |
| Earning per share | ||||||||||
| Basic earning per share | -300.00%-0.04 | --0 | -100.00%-0.04 | 113.33%0.02 | -92.31%0.02 | 108.33%0.01 | 71.43%-0.02 | -314.29%-0.15 | 188.89%0.26 | -200.00%-0.12 |
| Diluted earning per share | -300.00%-0.04 | --0 | -100.00%-0.04 | 113.33%0.02 | -92.31%0.02 | 108.33%0.01 | 71.43%-0.02 | -314.29%-0.15 | 188.89%0.26 | -200.00%-0.12 |
| Other composite income | ||||||||||
| Total composite income | -270.24%-20.28M | -85.36%893.49K | -161.13%-19.12M | 112.53%9.75M | -91.05%11.92M | 109.58%6.1M | 79.66%-7.32M | -313.49%-77.8M | 192.31%133.09M | -204.79%-63.72M |
| Total composite income of parent company owners | -299.40%-20.81M | -75.37%1.27M | -138.57%-18.73M | 111.83%9.26M | -92.11%10.44M | 108.12%5.17M | 78.24%-7.85M | -311.82%-78.22M | 187.45%132.22M | -203.90%-63.68M |
| Total composite income of minority owners | -64.57%524.17K | -140.85%-380.45K | -173.64%-389.47K | 18.10%491.16K | 70.11%1.48M | 2,298.83%931.43K | 531.12%528.92K | 185.94%415.88K | 286.61%869.76K | 91.18%-42.36K |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | China Audit Zhonghuan Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
